Use of Omalizumab will increase the pregnancy rate, proof of concept study, where women with asthma and infertility will be treated three times with weight and IgE balanced dosis at the first day of their period bleeding
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2019
Price : $35 *
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Pharmacodynamics; Proof of concept
- Acronyms PRO_ART
- 15 Jan 2019 Status changed from not yet recruiting to recruiting.
- 01 Nov 2018 Planned number of patients changed from 160 to 180.
- 30 Jul 2018 New trial record